Eclampsia Management
Administer intravenous magnesium sulfate immediately for seizure control and prophylaxis, urgently treat blood pressure ≥160/110 mm Hg with IV labetalol, hydralazine, or oral nifedipine, and proceed with delivery as the definitive treatment once the patient is stabilized.
Immediate Seizure Management
Magnesium Sulfate Administration
Magnesium sulfate is the first-line anticonvulsant for eclampsia, proven superior to other agents in preventing recurrent seizures 1, 2. The evidence is unequivocal—magnesium sulfate approximately halves the eclampsia rate 1.
Loading dose regimen 2:
- IV loading: 4-5 g diluted in 250 mL of 5% dextrose or 0.9% saline, infused over 15-20 minutes
- Alternative IV loading: 4 g as 10-20% solution over 3-4 minutes
- Simultaneous IM loading (if using combined approach): 10 g total (5 g in each buttock using undiluted 50% solution)
Maintenance dosing 2:
- IV maintenance: 1-2 g/hour by continuous infusion, OR
- IM maintenance: 4-5 g IM into alternate buttocks every 4 hours
Target therapeutic level: Serum magnesium of 6 mg/100 mL is optimal for seizure control 2.
Critical Monitoring During Magnesium Therapy
Monitor continuously for magnesium toxicity 1:
- Patellar reflexes: Must remain present (loss indicates impending toxicity)
- Respiratory rate: Must be ≥12 breaths/minute
- Urine output: Must be ≥30 mL/hour (≥0.5 mL/kg/hour)
Important caveat: In severe renal insufficiency, maximum dose is 20 g/48 hours with frequent serum magnesium monitoring 2.
Duration of Magnesium Therapy
Continue magnesium sulfate for 24 hours postpartum 1. While one Latin American study suggested 8 g pre-delivery may suffice without postpartum continuation, international guidelines recommend the full 24-hour postpartum course given the known risk of postpartum eclampsia 1.
Critical warning: Do not use magnesium sulfate continuously beyond 5-7 days in pregnancy as this causes fetal abnormalities 2.
Blood Pressure Management
Urgent Antihypertensive Treatment
Treat immediately when BP reaches ≥160/110 mm Hg 3, 1.
First-line agents 1:
- Oral nifedipine (immediate-release)
- IV labetalol
- IV hydralazine
The 2018 ISSHP guidelines emphasize that no single agent has proven superiority, so use the agent most familiar to your institution 1. The rate of IV injection for magnesium should not exceed 150 mg/minute except in severe eclampsia with active seizures 2.
Target Blood Pressure
Aim for diastolic BP of 85 mm Hg and systolic BP <160 mm Hg based on the CHIPS trial data 1. This "tight control" approach reduces the likelihood of developing severe maternal hypertension without compromising outcomes.
Fluid Management
Restrict total fluid intake to 60-80 mL/hour 1. This is critical because:
- Preeclamptic/eclamptic women have capillary leak
- Risk of pulmonary edema is substantial
- Aim for euvolemia, not volume expansion
- Replace insensible losses (30 mL/h) plus anticipated urinary output (0.5-1 mL/kg/hour)
Common pitfall: Do not "run dry" these patients—they are already at risk for acute kidney injury 1.
Timing and Mode of Delivery
Definitive Treatment
Delivery is the definitive treatment for eclampsia 3. Once the patient is stabilized with magnesium sulfate and blood pressure control, proceed with delivery.
Delivery Timing Algorithm
- Active eclampsia: Stabilize seizures and blood pressure first, then deliver promptly
- ≥34 weeks gestation: Recommend delivery after stabilization 3
- <34 weeks: Delivery still recommended given high risk of rapid maternal deterioration 3
Mode of Delivery
- Cesarean section is most commonly recommended for eclampsia 4
- Vaginal delivery only exceptionally appropriate if quick completion possible with stable maternal-fetal status 4
- Left lateral positioning essential during cesarean section 4
Anesthesia Considerations
- Regional anesthesia (neuraxial) preferred for conscious, seizure-free patients with stable vitals and no coagulopathy 5, 4
- General anesthesia required for emergency situations, active seizures, or coagulopathy—requires experienced team prepared for difficult intubation 4
Intrapartum Management
- Continue oral antihypertensives at labor onset 1
- IV antihypertensives may be needed due to reduced GI motility 1
- Maintain magnesium sulfate throughout labor and delivery
- Continue strict fluid restriction (60-80 mL/hour) 1
Postpartum Monitoring
Blood Pressure Surveillance
Monitor BP every 4-6 hours for at least 3 days postpartum 1. Eclampsia can occur de novo in the postpartum period.
Laboratory Monitoring
Repeat hemoglobin, platelets, creatinine, and liver transaminases the day after delivery, then every other day until stable if abnormal pre-delivery 1.
Antihypertensive Management
- Restart antihypertensives after delivery
- Taper slowly only after days 3-6 postpartum unless BP drops <110/70 mm Hg or patient becomes symptomatic 1
- Treat postpartum BP ≥150/100 mm Hg at minimum; many treat ≥140/90 mm Hg targeting <130/80 mm Hg 3
Pain Management
Avoid NSAIDs in eclamptic patients, especially with acute kidney injury—use alternative analgesia 1.
Key Safety Points
Maximum daily magnesium dose: 30-40 g per 24 hours in normal renal function 2
Signs of magnesium toxicity (in order of appearance):
- Loss of patellar reflexes
- Respiratory depression
- Cardiac arrest
Magnesium toxicity antidote: Calcium gluconate 1 g IV (10 mL of 10% solution) should be immediately available.